While it might not seem like it, less than half (49.7%) of the population of the United States of America have received the COVID-19 vaccination. This means that more than fifty percent of Americans are still faced with the decision of whether to receive the vaccine. As talk of the looming Delta variant increases, it is up to those who have yet to be vaccinated to do their research and determine if it is in their best interest to receive the vaccine, despite pressure from the government, social media, and mainstream media. Making an informed decision becomes even more difficult as with each new health announcement “trusted doctors” such as Dr. Anthony Fauci and Public Health Organizations like the CDC seem to contradict previous statements, rules and regulations.  

First, it is important to note that currently, there is no FDA-approved vaccine to prevent COVID-19. Rather, the Janssen, Pfizer, and Moderna COVID-19 Vaccine are all still being studied in clinical trials and have been approved only under an Emergency Use Authorization. Up until a few days ago, American citizens have upheld the liberty to make their own medical decision regarding their body. However, just a few days ago, the DOJ has begun changing laws regarding the legality of mandating the COVID-19 Vaccine. Furthermore, should you receive the vaccine, and something goes wrong, you will not have the ability to sue or receive compensation from drug manufactures such as Johnson & Johnson, as the federal government has granted total immunity to all vaccine manufactures. With this information in mind, if you do decide to become a human subject in this trial, it is of top concern to fully understand the risks and drawbacks of receiving the vaccine at this point. Unfortunately, due to censorship and a lack of transparency amongst mainstream media and public healthcare organizations and officials, this information is difficult to come across.  

For instance, let’s say you are completely healthy individual below the age of 70, with no medical illnesses or problems deciding whether or not to receive the Jannsen COVID-19 Vaccine. Each vaccine manufacturer provides a “fact sheet” for recipients and care givers to those who are receiving or taking care of an individual receiving the vaccine. The “fact sheet” covers information such as the ingredients, risks and benefits of the vaccine. Let’s look at the risk portion of the Janssen Fact Sheet for Recipients and Caregivers. One severe side effect that Johnson and Johnson reports is the possibility of blood clots and low levels of platelets, which are likely to occur one to two weeks following vaccination and have had the highest reports in females aging from 18-49.   According to Johnson & Johnson, “the chances of having this occur are remote.” Despite Johnson and Johnson’s minimization of a potentially deadly risk associated with the vaccine, on April 13th, the FDA and CDC temporarily halted the distribution of the Janssen COVID-19 Vaccine while the company investigated the “remote” occurrences of blood clotting and low levels of platelets. This temporary halt was lifted just 10 short days later. In the past, the pausing of a vaccine due to safety concerns has comprised of months to years of research and thus no administration of the said vaccine. It is unclear how effective a 10-day pause is in reassessing the Janssen COVID-19 Vaccine. 

Aside from blood clotting and low platelet levels, Johnson & Johnson also reports cases of Guillain Barre which is a neurological disorder where the body’s immune system attacks nerve cells causing muscle weakness and paralysis occurring in those who have received the Janssen COVID-19 Vaccine. However, in the vaccine fact sheet, Johnson & Johnson states that “the chance of having this occur is very low.” In general, contracting the Guillain Barre Disease is very rare, as an estimated 3,000-6,000 Americans are diagnosed each year. So, while VEARS has only reported around 100 cases of GBS from the Jannsen Vaccine alone, considering the rarity of the disease in the United States, 100 reported cases of GBS due to the vaccine is quite high. 

While Johnson & Johnson is the only vaccine manufacturer cited here, they are not alone in mitigating the risks of receiving the COVID-19 Vaccine, as the Fact Sheet for Recipients and Caregivers of both Pfizer and Moderna work to minimize the severity of adverse reactions from their respective vaccinations as well. 

On the contrary to these serious risk factors that accompany the COVID-19 Vaccine, let us look at the symptoms that occur when contracting COVID-19 itself. According to the CDC, common side effects of COVID-19 include fatigue, shortness of breath, cough, joint pain, headaches, loss of smell or taste, fever, and dizziness.  Furthermore, let us not forget that for individuals ranging 0-69, the survival rate of COVID-19 is 99%. Contrary, VAERS data released by the CDC shows that between December 14, 2020 through July there were 10,991 deaths and 463,457 adverse events following the receival of the COVID-19 Vaccine in the United States alone. The number of reports regarding the COVID-19 Vaccine is unprecedented for the program which was created in 1990. 

Furthermore, in terms of receiving a vaccine such as the Jannsen COVID-19 Vaccine as a means of protecting yourself against the “threatening” delta variant, note that as of July 22, 2021 India, a country that was overwhelmed with cases of COVID-19 delta variant cases back in October, have recorded a 97.35% recovery rate. This data was reported by CNBC just last week, although expectedly, the positive recovery rate data is muddled beneath paragraphs of alternate information which serves as a campaign for readers to “do their part” in receiving the vaccine to protect against the delta variant: despite a 97% recovery rate. 

Moreover, when it comes to immunity to the delta variant or any other variants of COVID-19 that might arise in years to come, it is actually more beneficial, and arguably safer, to attain natural immunity. While mainstream media as well as public health officials have been pushing the narrative that vaccine-induced immunity exceeds natural immunity, recent data collected from Israel, a country with more than 60% of its population vaccinated proves otherwise. On July 13, 2021, the Israeli Health Ministry reported that out of the 7,700 COVID-19 cases reported since May 2021, only 72 of those individuals had previously had COVID-19, a rate of less than 1%. On the contrary, more than 3,000 of those individuals, about 40%, had received the COVID-19 Vaccine. In short, those who had “vaccine induced immunity” were actually 700 % more likely to develop COVID-19 then those who had natural immunity. This is because when an individual is naturally infected, hundreds of antibodies are induced against all proteins of the virus, which in turn create a broad immunity that cannot be matched by vaccination.  

Not only will you be better protected against any COVID-19 variants, but natural immunity is also proving to be longer lasting than the COVID-19 Vaccination. It was reported that those who had recovered from SARS-CoV, a virus which belongs to the same viral species and is genetically similar to SARS-CoV-2, had notable levels of neutralizing antibodies at least 17 years after the initial infection. On the other hand, according to Pfizer’s head of medical research and development, those who were vaccinated early, around January, are becoming more susceptible to the virus due to a decline in antibodies.  

Currently, the American public is being engulfed by the narrative that “getting vaccinated” is the right, and only choice that we have. In turn, millions of Americans are needlessly putting their lives at risk by receiving the vaccine for a disease with a survival rate of 99%. Before conforming to this fallacious narrative, consider your own health and search for your own information regarding the safest route to take when it comes to receiving the COVID-19 Vaccine. 





Jim Baker

Jim Baker

Sumus was founded by Jim Baker, an entrepreneur with 27 years’ experience bootstrapping and growing his business organically and through acquisition, to share his experience by providing advisory services around Board representation, Organization and Branding Strategy, Mergers & Acquisitions, Value enhancement and Exit strategy.